Related Experiment Video
Updated: Jan 17, 2026
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
Published on: June 28, 2019
Patient-Derived Neurons Exhibit α-Synuclein Pathology and Previously Unrecognized Major Histocompatibility Complex
Leonie M Heger1, Leonie Kertess1, Clara Kaufhold1
1Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany.
Background:
Mitochondrial membrane protein-associated neurodegeneration (MPAN) from the neurodegeneration with brain iron accumulation (NBIA) family is a rare neurodegenerative disease marked by α-synuclein aggregation, brain iron accumulation, and midbrain dopaminergic neuron degeneration.
Objective:
The mechanisms driving neuron vulnerability remain unclear. Our study aimed to develop a patient-derived disease model replicating key pathologies of patient brains.
Methods:
We generated induced pluripotent stem cell-derived midbrain dopaminergic neurons from MPAN patients and examined ultrastructural and biochemical markers of pathology.
Results:
MPAN patient neurons displayed α-synuclein aggregation, axonal swellings, iron accumulation, and severe membrane destruction. In addition, levels of the major histocompatibility complex class I (MHC-I), linked to cellular stress and neurodegenerative processes, were elevated in patient neurons. Treatment with acetyl-leucine, a potentially neuroprotective compound, decreased MHC-I.
Conclusions:
This first patient-derived neuronal model of MPAN provides a useful tool for further research aimed at unraveling the complexities of this disease and developing potential therapeutic interventions. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Insights
Researchers developed a patient-derived model for Mitochondrial membrane protein-associated neurodegeneration (MPAN), revealing key pathologies like alpha-synuclein aggregation and iron accumulation. This model aids in understanding MPAN disease mechanisms and exploring treatments.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a rare neurodegenerative disease within the neurodegeneration with brain iron accumulation (NBIA) family.
- MPAN is characterized by alpha-synuclein aggregation, iron accumulation in the brain, and degeneration of midbrain dopaminergic neurons.
Purpose of the Study:
- To investigate the underlying mechanisms of neuron vulnerability in MPAN.
- To create a patient-derived disease model that replicates the key pathological features observed in MPAN patient brains.
Main Methods:
- Generated induced pluripotent stem cell-derived midbrain dopaminergic neurons from MPAN patients.
- Examined ultrastructural and biochemical markers of pathology in these patient-derived neurons.
Main Results:
- MPAN patient neurons exhibited alpha-synuclein aggregation, axonal swellings, iron accumulation, and significant membrane damage.
- Elevated levels of major histocompatibility complex class I (MHC-I), a marker of cellular stress, were observed in patient neurons.
- Treatment with acetyl-leucine reduced MHC-I levels, suggesting a potential neuroprotective effect.
Conclusions:
- The developed patient-derived neuronal model represents the first of its kind for MPAN.
- This model serves as a valuable tool for further research into MPAN's complex mechanisms.
- The model can facilitate the development of potential therapeutic strategies for MPAN.
More Related Videos
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
